Nano Dimension Ltd.
7.90%
16,715,812
1643303
Jul 22, 2026
Jul 27, 2026, 07:06 PM
Reporting Persons (7)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | Other | 7.90% | 16,715,812 | 0 | 16,715,812 |
| KEVIN TANG | Individual | 7.90% | 16,715,812 | 0 | 16,715,812 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | Partnership | 2.50% | 5,223,680 | 0 | 5,223,680 |
| TANG CAPITAL PARTNERS, LP | Partnership | 1.80% | 3,830,718 | 0 | 3,830,718 |
| TANG CAPITAL PARTNERS III, INC | CO | 1.80% | 3,830,712 | 0 | 3,830,712 |
| TANG CAPITAL PARTNERS IV, INC | CO | 1.80% | 3,830,702 | 0 | 3,830,702 |
| CONCENTRA BIOSCIENCES, LLC | Other | 0.00% | 0 | 0 | 0 |
Disclosure Items (4)
Ordinary Shares par value NIS 5.00 per share
Nano Dimension Ltd.
60 Tower Road, Waltham, MA, 02451
Item 3 of the Original Schedule 13D is hereby amended to add the following: Since June 30, 2026 the Reporting Persons have expended an aggregate of approximately $3.6 million to purchase 2,422,999 of the Issuer's Ordinary Shares through the open market. The Ordinary Shares were acquired in the ordinary course of business.
The information previously provided in response to Item 5 is hereby amended and restated by replacing the text thereof in its entirety with the following: The information set forth in the cover pages of this Schedule 13D is hereby incorporated by reference into this Item 5. As of the date hereof the Reporting Persons beneficially own an aggregate of 16,715,812 shares of the Issuer's Ordinary Shares, representing 7.9% of the outstanding shares.
See item 5(a) above.
Schedule A attached hereto as Exhibit 3 describes all transactions in the Issuer's Ordinary Shares that were effected during the past 60 days by the Reporting Persons.
No person other than a Reporting Person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, Ordinary Shares beneficially owned by the Reporting Persons.
Not applicable
Exhibit 1: Joint Filing Agreement by and among the Reporting Persons (filed as Exhibit 1 of the 13D filed on June 30, 2026 by the Reporting Persons with respect to the Ordinary Shares of the Issuer). Exhibit 2: Merger Proposal, dated June 30, 2026, sent from TCM to the Issuer (filed as Exhibit 2 of the 13D filed on June 30, 2026 by the Reporting Persons with respect to the Ordinary Shares of the Issuer). Exhibit 3: Schedule A: Transactions during the past 60 days (as amended).